Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

2010456 citationsJournal Article

Authors

Good health and well-being

Published in: American Heart Journal

Volume 159, Issue 3, pp. 331-339

Field-Weighted Citation Impact: 36.18